| Page 5 | Kisaco Research

Author:

Jeff Miller

Chief Growth Officer
Sequel Brands

With over 20 years of marketing experience spanning boutique fitness, yoga, health and wellness franchising, and the surf industry, Jeff serves as the Chief Marketing Officer for YogaSix, part of Xponential Fitness. Prior to YogaSix, he was in marketing leadership positions with Row House, Orangetheory Fitness, Upgrade Labs, and YogaWorks.  A father of two teens and passionate surfer, he also enjoys yoga, snowboarding, golf, and cheering on his LA Lakers and Dodgers. Jeff is a 27-year LA County Ocean Lifeguard and the President of a nonprofit foundation that uses ocean therapy to support at-risk youth, first responders, and veterans.

Jeff Miller

Chief Growth Officer
Sequel Brands

With over 20 years of marketing experience spanning boutique fitness, yoga, health and wellness franchising, and the surf industry, Jeff serves as the Chief Marketing Officer for YogaSix, part of Xponential Fitness. Prior to YogaSix, he was in marketing leadership positions with Row House, Orangetheory Fitness, Upgrade Labs, and YogaWorks.  A father of two teens and passionate surfer, he also enjoys yoga, snowboarding, golf, and cheering on his LA Lakers and Dodgers. Jeff is a 27-year LA County Ocean Lifeguard and the President of a nonprofit foundation that uses ocean therapy to support at-risk youth, first responders, and veterans.

GLP-1 medications are reshaping why people walk through your doors, and what they expect when they do. We’ll explore how gyms, studios and clubs are responding with medical partnerships, habit coaching, adaptive programming that complements pharmacological weight loss and more. Walk away with actionable strategies to stay relevant, retain members, and create new revenue streams in this fast-evolving health landscape.

Author:

Tracy J Sims

Executive Director of Corporate Affairs - Diabetes and Obesity Care
Eli Lilly

Tracy Sims is Executive Director, Cardiometabolic Health Corporate Affairs at Eli Lilly and Company.  He leads health system analysis and policy modernization efforts for chronic diseases including obesity and diabetes.  Tracy’s role includes real-world evidence research, and he has authored papers in both obesity and diabetes care. He is an ex-officio member of the National Academies of Sciences, Engineering, and Medicine serving on the Roundtable On Obesity Solutions. Tracy holds a Master of Arts in Sociology from the University of Alabama at Birmingham.

Tracy J Sims

Executive Director of Corporate Affairs - Diabetes and Obesity Care
Eli Lilly

Tracy Sims is Executive Director, Cardiometabolic Health Corporate Affairs at Eli Lilly and Company.  He leads health system analysis and policy modernization efforts for chronic diseases including obesity and diabetes.  Tracy’s role includes real-world evidence research, and he has authored papers in both obesity and diabetes care. He is an ex-officio member of the National Academies of Sciences, Engineering, and Medicine serving on the Roundtable On Obesity Solutions. Tracy holds a Master of Arts in Sociology from the University of Alabama at Birmingham.

Author:

James LaValle

Chief Science Officer
Life Time

James LaValle

Chief Science Officer
Life Time